ANROAlto Neuroscience, Inc.
What is the market doing?
Rangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Choppy, but holding above its 200-day average. Oversold (RSI 13). Price is +1% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ANRO is trading
Alto Neuroscience, Inc. is +304% over the past year while the S&P 500 is +18%: 286 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +0.75%
vs 200-day average · close to trend
- RSI (14)
- 13
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 34%
Below its 52-week high
Details›
- Last close2026-10-08
- $24.00
- 1 monthS&P 500 +1.6%
- −30%
- 1 yearS&P 500 +18%
- +304%
- vs 50-day average$30.63
- −22%
- 52-week high
- $36.62
- 52-week low
- $5.62
- Annualised volatility
- 117%
| Year | Return |
|---|---|
| 2026 (year to date) | +35% |
| 2025 | +321% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 1 of 2 | −5.8% |
| Feb | 2 | 1 of 2 | −3.8% |
| Mar | 3 | 1 of 3 | −3.0% |
| Apr | 3 | 3 of 3 | +10% |
| May | 3 | 1 of 3 | −14% |
| Jun | 3 | 1 of 3 | +2.1% |
| Jul | 3 | 3 of 3 | +14% |
| Aug | 3 | 3 of 3 | +23% |
| Sep | 3 | 1 of 3 | −9.8% |
| Oct | 3 | 1 of 3 | +60% |
| Nov | 2 | 1 of 2 | +5.5% |
| Dec | 2 | 1 of 2 | +12% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry